Egualen Sodium Granules

Similar documents
Ondansetron Hydrochloride Tablets

LUMEFANTRINUM LUMEFANTRINE

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

EFAVIRENZ Final text for addition to The International Pharmacopoeia

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

ANALYTICAL METHOD PROCEDURES

ADVANTAME. Not less than 97.0% and not more than 102.0% on the anhydrous basis. Sweetener, flavour enhancer

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

Additionally, minor editorial changes have been made to update the monograph to current USP style.

ADVANTAME (TENTATIVE)

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009)

Revision Bulletin Official April 1, 2014 Alprazolam 1

Chapter 4: Verification of compendial methods

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007)

This method describes the identification of the following prohibited colorants in cosmetic products:

Chem 321 Name Answer Key D. Miller

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

USP 35 Official Monographs / Oxaliplatin 4143 DEFINITION

A. GENERAL NOTICES. Ninth Edition, which may be abbreviated as JSFA-IX.

School of Chemistry UNIVERSITY OF KWAZULU-NATAL, WESTVILLE CAMPUS JUNE 2009 EXAMINATION CHEM340: INSTRUMENTAL ANALYSIS.

Dehydrated Alcohol. » Dehydrated Alcohol contains not less than 99.2 percent, Pharmacopeial Forum Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Amendment to the Enforcement Ordinance of the Food Sanitation Law and the Standards and Specifications for Foods and Food Additives.

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component)

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

MEDROXYPROGESTERONE INJECTION

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

1-(2-METHOXYPHENYL)PIPERAZINE Latest revision: June 27, 2005

Chapter 5: Identification, Assay and Related Substances

ASPARTAME. Not less than 98% and not more than 102% on the dried basis. White, odourless, crystalline powder, having a strong sweet taste

Supporting Information For:

TERTIARY BUTYLHYDROQUINONE

Supplementary Note 1 : Chemical synthesis of (E/Z)-4,8-dimethylnona-2,7-dien-4-ol (4)

637. Thiamethoxam. HPLC method

BENZYLPIPERAZINE Latest Revision: June 1, 2005

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

IDENTIFICATION TESTS FOR DURACOR TABLETS

Dissolution Test 2 was validated using an Inertsil ODS-3V brand of L1 column. The typical retention time for donepezil is about 5.5 min.

POLYVINYL ALCOHOL. SYNONYMS Vinyl alcohol polymer, PVOH, INS No DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

SECOBARBITAL Latest Revision: February 15, 1999

PYRIPROXYFEN TECHNICAL

PHYSICAL CONSTANTS: MELTING POINTS, BOILING POINTS, DENSITY

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

National standard of People s Republic of China

BUFOTENINE Latest Revision: August 16, 2005

Diquat 1,1 -ethylene-2,2 -bipyridium dibromide salt Paraquat 1,1 -dimethyl-4,4 -bipyridium dichloride salt Initial Preparation

Period of validity: to date of issue:

Introduction to Pharmaceutical Chemical Analysis

METHOD 8032A ACRYLAMIDE BY GAS CHROMATOGRAPHY

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

CHAPTER 8 ISOLATION AND CHARACTERIZATION OF PHYTOCONSTITUENTS BY COLUMN CHROMATOGRAPHY

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

16 Malachite green 17 Leucomalachite green

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Annex to the Accreditation Certificate D-RM according to ISO Guide 34:2009 and DIN EN ISO/IEC 17025:2005

Method for Characterization of Gum Rosin by Capillary Gas Chromatography

Supporting Information

Electronic Supplementary Material (ESI) for Medicinal Chemistry Communications This journal is The Royal Society of Chemistry 2012

Synthesis of Tetraphenylcyclopentadienone. Becky Ortiz

Chromatography Extraction and purification of Chlorophyll CHM 220

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

Supplementary Material (ESI) for Chemical Communication

Chemical synthesis (see also reaction scheme, bold underlined numbers in this text refer to the bold underlined numbers in the scheme)

Multistep Synthesis of 5-isopropyl-1,3-cyclohexanedione

Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers.

Effect of Conjugation and Aromaticity of 3,6 Di-substituted Carbazole On Triplet Energy

Tex-620-J, Determining Chloride and Sulfate Contents in Soil

Abstract. Introduction

(a) Name the alcohol and catalyst which would be used to make X. (2)

Automatic determination of the bromine number and the bromine index in petroleum products

Supporting Information

Lonicera japonica Flower Powder. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Electronic Supplementary Information for. A Redox-Nucleophilic Dual-Reactable Probe for Highly Selective

Supporting Information for:

RediSep Rf C18 Flash Column Loading Techniques

University of Wisconsin Chemistry 116 Preparation and Characterization of Aspirin and Some Flavoring Esters *

Synthesis of Secondary and Tertiary Amine- Containing MOFs: C-N Bond Cleavage during MOF Synthesis

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

Figure S1 - Enzymatic titration of HNE and GS-HNE.

Acidimetry in Non-Aqueous Titrations

SYNTHESIS OF 1-BROMOBUTANE Experimental procedure at macroscale (adapted from Williamson, Minard & Masters 1 )

Supporting Information

Transcription:

Egualen Sodium Granules Dissolution <6.10> Weigh accurately an amount of Egualen Sodium Granules, equivalent to about 5 mg of egualen sodium (C 15 H 17 NaO 3 S 1/3 H2O) according to the labeled amount, and perform the test at 75 revolutions per minute according to the Paddle method, using 900 ml of 2nd fluid for dissolution test as the dissolution medium. Start the test, withdraw not less than 20 ml of the medium at the specified minute after starting the test, and filter through a membrane filter with a pore size not exceeding 0.45 µm. Discard the first 10 ml of the filtrate, and use the subsequent filtrate as the sample solution. Separately, weigh accurately about 22 mg of Egualen Sodium RS (separately, determine the water <2.48> with 0.5 g by direct titration in volumetric titration), and dissolve in 2nd fluid for dissolution test to make exactly 100 ml. Pipet 5 ml of this solution, add 2nd fluid for dissolution test to make exactly 200 ml, and use this solution as the standard solution. Determine the absorbances, A T and A S, at 284 nm of the sample solution and standard solution as directed under Ultraviolet-visible Sectrophotometry <2.24>. The requirements are met if Egualen Sodium Granules conform to the dissolution requirements. Dissolution rate (%) with respect to the labeled amount of egualen sodium (C 15 H 17 NaO 3 S 1/3 H 2 O) = M S /M T A T /A S 1/C 45/2 1.020 M S : Amount (mg) of Egualen Sodium RS, calculated on the anhydrous basis M T : Amount (g) of sample C: Labeled amount (mg) of egualen sodium (C 15 H 17 NaO 3 S 1/3 H 2 O) in 1 g Dissolution Requirements Labeled amount Specified minute Dissolution rate 25 mg/g 15 minutes Not less than 85% Egualen Sodium RS C 15 H 17 NaO 3 S 1/3 H 2 O: 306.35 Sodium 3-ethyl-7-isopropyl-1- azulenesulfonate 1/3 hydrate. It meets the following requirements. Purify according to the following method if needed. Purification method Dissolve 10 g of egualen sodium in 30 ml of ethanol (99.5) by warming, and filter while warm. After cooling, collect the separated crystals, and wash with two 2-mL portions of ethanol (99.5). Recrystalize in ethanol (99.5), and wash the crystals so obtained with two 5-mL

portions of ethanol (99.5). Dry the crystals so obtained at 80ºC for 2 hours, and allow to cool in a desiccator with silica gel. Description Egualen Sodium RS occurs as blue, crystals or crystalline powder. Identification (1) Determine the absorption spectrum of a solution of Egualen Sodium RS (1 in 4000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits a maximum between 580 nm and 584 nm. Also, determine the absorption spectrum of a solution of Egualen Sodium RS (1 in 200000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits maxima between 237 nm and 241 nm, between 283 nm and 287 nm, and between 293 nm and 297 nm. (2) Determine the infrared absorption spectrum of Egualen Sodium RS, previously dried, as directed in the potassium bromide disk method under Infrared Spectrophotometry <2.25>: it exhibits absorption at the wave numbers of about 2950 cm -1, 1576 cm -1, 1385 cm -1, 1179 cm -1 and 1047 cm -1. (3) Determine the 1 H spectrum of a solution of Egualen Sodium RS in deuterated methanol for nuclear magnetic resonance spectroscopy (1 in 50), using tetramethylsilane for nuclear magnetic resonance spectroscopy as an internal reference compound, as directed under Nuclear Magnetic Resonance Spectroscopy <2.21>: it exhibits a multiple signal A at around δ 1.4 ppm, a broad multiple signal B at around δ 3.0 ppm, a triplet signal C at around δ 7.2 ppm, a double signal D at around δ 7.7 ppm, a single signal E at around δ 8.0 ppm, a double signal F at around δ 8.3 ppm, and a single or a slightly splitting double signal G at around δ 9.2 ppm. The ratio of integrated intensity of each signal, A:B:C:D:E:F:G, is about 9:3:1:1:1:1:1. Purity (1) 1-ethyl-5-isopropylazulene and 1,3-diethyl-5-isopropylazulene Dissolve 20 mg of Egualen Sodium RS in methanol to make exactly 100 ml, and use this solution as the sample solution. Separately, dissolve 10 mg each of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene in methanol to make them exactly 100 ml. Pipet 1 ml each of these solutions, add methanol to make them exactly 50 ml. Pipet 1 ml each of these solutions, add methanol to make them exactly 50 ml, and use these solutions as the standard solution (1) and standard solution (2). Perform the test with exactly 20 μl each of the sample solution, standard solution (1) and standard solution (2) as directed under Liquid Chromatography <2.01> according to the following conditions, and determine each peak area by the automatic integration method: the peak area of 1-ethyl-5- isopropylazulene obtained from the sample solution is not larger than that from the standard solution (1), and the peak area of 1,3-diethyl-5-isopropylazulene obtained from the sample solution is not larger than that from the standard solution (2).

Column temperature: A constant temperature of about 20ºC. adjust the ph to 6.0 with a solution prepared by dissolving 7.2 g of disodium hydrogen phosphate dodecahydrate in water to make 1000 ml. To 100 ml of this solution add 400 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of 1-ethyl-5-isopropylazulene is about 9 minutes. Time span of measurement: About 2 times as long as the retention time of 1-ethyl-5- isopropylazulene. System performance: Dissolve 10 mg each of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene in methanol to make 100 ml. To 1 ml each of these solutions add methanol to make 50 ml. To 1 ml of this solution add methanol to make 50 ml, and use this solution as the solution for system suitability test. When the procedure is run with 20 µl of the solution for system suitability test under the above operating conditions, 1-ethyl-5-isopropylazulene and 1,3-diethyl-5-isopropylazulene are eluted in this order with the resolution between these peaks being not less than 3. System repeatability: When the test is repeated 6 times with 20 µl of the solution for system suitability test under the above operating conditions, the relative standard deviations of the peak areas of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5-isopropylazulene are not more than 2.0%, respectively. (2) Related substances Dissolve 20 mg of Egualen Sodium RS in 100 ml of the mobile phase, and use this solution as the sample solution. Pipet 1 ml of this solution, and add the mobile phase to make exactly 100 ml. Pipet 5 ml of this solution, add the mobile phase to make exactly 100 ml, and use this solution as the standard solution. Perform the test with exactly 20 µl each of the sample solution and standard solution as directed under Liquid Chromatography <2.01> according to the following conditions. Determine each peak area of both solutions by the automatic integration method: the total area of the peaks, having the relative retention time of not less than 0.25 with respect to egualen, obtained from the sample solution is not larger than the peak area of egualen from the standard solution, and the total area of the peaks having the relative retention time of not more than 0.25 with respect to egualen, obtained from the sample solution is not larger than the peak area of egualen from the standard solution. Column temperature: A constant temperature of about 20ºC.

adjust the ph to 6.0 with a solution prepared by dissolving 7.2 g of disodium hydrogen phosphate dodecahydrate in water to make 1000 ml. To 700 ml of this solution add 300 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of egualen is about 12 minutes. Time span of measurement: About 2 times as long as the retention time of egualen. Test for required detectability: Pipet 5 ml of the standard solution, and add the mobile phase to make exactly 25 ml. Confirm that the peak area of egualen obtained from 20 µl of this solution is equivalent to 15 to 25% of that from 20 µl of the standard solution. System performance: To 10 mg of methyl parahydroxybenzoate add 5 ml of the sample solution, and add the mobile phase to make 25 ml. When the procedure is run with 20 µl of this solution under the above operating conditions, methyl parahydroxybenzoate and egualen are eluted in this order with the resolution between these peaks being not less than 2.0. System repeatability: When the test is repeated 6 times with 20 µl of the standard solution under the above operating conditions, the relative standard deviation of the peak area of egualen is not more than 5%. Water <2.48>: 1.8 2.2% (0.5 g, volumetric titration, direct titration). Content: not less than 99.0% of egualen sodium (C 15 H 17 NaO 3 S: 300.35), calculated on the anhydrous basis. Assay Weigh accurately about 0.3 g of Egualen Sodium RS, dissolve in 30 ml of water, apply to a chromatographic column, 15 mm in diameter, previously prepared with 2 g of strongly acidic ion exchange resin for column chromatography (type H), and allow to flow at a rate of 5 ml per minute. Wash the column with 50 ml of water, combine the washing and the former effluent solution, and titrate <2.50> with 0.05 mol/l sodium hydroxide VS (potentiometric titration). Perform a blank determination in the same manner, and make any necessary correction. Each ml of 0.05 mol/l sodium hydroxide VS = 15.02 mg of C 15 H 17 NaO 3 S 1-Ethyl-5-Isopropylazulene C 15 H 18 A clear and blue liquid. Identification (1) Determine the absorption spectrum of a solution of 1-Ethyl-5-Isopropylazulene in methanol (1 in 4000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits a maximum between 613 nm and 617 nm. Also, determine the absorption spectrum of a solution of 1- Ethyl-5-Isopropylazulene in methanol (1 in 400000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits a maximum between 279 nm and 283 nm. (2) Determine the infrared absorption spectrum of 1-Ethyl-5-Isopropylazulene as directed in the liquid film method under Infrared Spectrophotometry <2.25>: it exhibits absorption at the wave numbers of about 2950 cm -1 and 1572 cm -1.

Related substances Dissolve 10 mg of 1-Ethyl-5-Isopropylazulene in 100 ml of methanol, and use this solution as the sample solution. Pipet 1 ml of this solution, add methanol to make exactly 100 ml, and use this solution as the standard solution. Perform the test with exactly 20 µl each of the sample solution and standard solution as directed under Liquid Chromatography <2.01> according to the following conditions. Determine each peak area of both solutions by the automatic integration method: the total area of the peaks other than 1-ethyl-5-isopropylazulene obtained from the sample solution is not larger than the peak area of 1-ethyl-5-isopropylazulene from the standard solution. Column temperature: A constant temperature of about 20ºC. adjust the ph to 6.0 with a solution prepared by dissolving 7.2 g of disodium hydrogen phosphate dodecahydrate in water to make 1000 ml. To 100 ml of this solution add 400 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of 1-ethyl-5-isopropylazulene is about 9 minutes. Time span of measurement: About 2 times as long as the retention time of 1-ethyl-5- isopropylazulene. Test for required detectability: Pipet 1 ml of the standard solution, and add methanol to make exactly 20 ml. Confirm that the peak area of 1-ethyl-5-isopropylazulene obtained from 20 µl of this solution is equivalent to 3.5 to 6.5% of that from 20 µl of the standard solution. System performance: Dissolve 10 mg each of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene in methanol to make 100 ml. To 1 ml each of these solutions add methanol to make 50 ml. To 1 ml of this solution add methanol to make 50 ml, and use this solution as the solution for system suitability test. When the procedure is run with 20 µl of the solution for system suitability test under the above operating conditions, 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene are eluted in this order with the resolution between these peaks being not less than 3. System repeatability: When the test is repeated 6 times with 20 µl of the solution for system suitability test under the above operating conditions, the relative standard deviations of the peak areas of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5-isopropylazulene are not more than 10%, respectively.

1,3-Diethyl-5-Isopropylazulene C 17 H 22 A clear and blue liquid. Identification (1) Determine the absorption spectrum of a solution of 1,3-Diethyl-5- Isopropylazulene in methanol (1 in 4000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits a maximum between 640 nm and 644 nm. Also, determine the absorption spectrum of a solution of 1,3-Diethyl-5-Isopropylazulene in methanol (1 in 400000) as directed under Ultraviolet-visible Spectrophotometry <2.24>: it exhibits a maximum between 282 nm and 286 nm. (2) Determine the infrared absorption spectrum of 1,3-Diethyl-5-Isopropylazulene as directed in the liquid film method under Infrared Spectrophotometry <2.25>: it exhibits absorption at the wave numbers of about 2950 cm -1 and 1572 cm -1. Related substances Dissolve 10 mg of 1,3-Diethyl-5-Isopropylazulene in 100 ml of methanol, and use this solution as the sample solution. Pipet 1 ml of this solution, add methanol to make exactly 100 ml, and use this solution as the standard solution. Perform the test with exactly 20 µl each of the sample solution and standard solution as directed under Liquid Chromatography <2.01> according to the following conditions. Determine each peak area of both solutions by the automatic integration method: the total area of the peaks other than 1,3-diethyl-5-isopropylazulene obtained from the sample solution is not larger than the peak area of 1,3-diethyl-5-isopropylazulene from the standard solution. Column temperature: A constant temperature of about 20ºC. adjust the ph to 6.0 with a solution prepared by dissolving 7.2 g of disodium hydrogen phosphate dodecahydrate in water to make 1000 ml. To 100 ml of this solution add 400 ml of acetonitrile. Flow rate: Adjust the flow rate so that the retention time of 1,3-diethyl-5-isopropylazulene is about 15 minutes. Time span of measurement: About 2 times as long as the retention time of 1,3-diethyl-5- isopropylazulene. Test for required detectability: Pipet 1 ml of the standard solution, and add methanol to make exactly 20 ml. Confirm that the peak area of 1,3-diethyl-5-isopropylazulene obtained from 20 µl of this solution is equivalent to 3.5 to 6.5% of that from 20 µl of the standard solution. System performance: Dissolve 10 mg each of 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene in methanol to make 100 ml. To 1 ml each of these solutions add methanol to

make 50 ml. To 1 ml of this solution add methanol to make 50 ml, and use this solution as the solution for system suitability test. When the procedure is run with 20 µl of the solution for system suitability test under the above operating conditions, 1-ethyl-5-isopropylazulene and 1,3-diethyl-5- isopropylazulene are eluted in this order with the resolution between these peaks being not less than 3. System repeatability: When the test is repeated 6 times with 20 µl of the solution for system suitability test under the above operating conditions, the relative standard deviations of the peak areas of 1-ethyl-5- isopropylazulene and 1,3-diethyl-5-isopropylazulene are not more than 10%, respectively.